BWAY Stock Overview
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
BrainsWay Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪9.60 |
| 52 Week High | ₪14.01 |
| 52 Week Low | ₪2.72 |
| Beta | 0.34 |
| 1 Month Change | -13.04% |
| 3 Month Change | -19.46% |
| 1 Year Change | 196.94% |
| 3 Year Change | -29.77% |
| 5 Year Change | -52.71% |
| Change since IPO | -37.76% |
Recent News & Updates
Recent updates
BrainsWay Ltd.'s (TLV:BWAY) P/S Is Still On The Mark Following 26% Share Price Bounce
Dec 25
We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely
Dec 21We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely
Sep 19We're Keeping An Eye On BrainsWay's (TLV:BWAY) Cash Burn Rate
Jun 01We Think BrainsWay (TLV:BWAY) Can Afford To Drive Business Growth
Aug 15BrainsWay (TLV:BWAY) Is In A Good Position To Deliver On Growth Plans
May 13BrainsWay (TLV:BWAY) Is In A Strong Position To Grow Its Business
Jan 31What Is The Ownership Structure Like For Brainsway Ltd. (TLV:BWAY)?
Mar 02What Type Of Returns Would Brainsway's(TLV:BWAY) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Jan 25
Brainsway Ltd. (TLV:BWAY): Is Breakeven Near?
Dec 26Shareholder Returns
| BWAY | IL Medical Equipment | IL Market | |
|---|---|---|---|
| 7D | -5.0% | -2.7% | -0.7% |
| 1Y | 196.9% | 5.0% | 10.4% |
Return vs Industry: BWAY exceeded the IL Medical Equipment industry which returned 4.1% over the past year.
Return vs Market: BWAY exceeded the IL Market which returned 8.3% over the past year.
Price Volatility
| BWAY volatility | |
|---|---|
| BWAY Average Weekly Movement | 7.3% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.4% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: BWAY's share price has been volatile over the past 3 months.
Volatility Over Time: BWAY's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 134 | Hadar Levy | www.brainsway.com |
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry.
BrainsWay Ltd. Fundamentals Summary
| BWAY fundamental statistics | |
|---|---|
| Market cap | ₪319.43m |
| Earnings (TTM) | -₪15.93m |
| Revenue (TTM) | ₪120.64m |
2.6x
P/S Ratio-20.1x
P/E RatioIs BWAY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BWAY income statement (TTM) | |
|---|---|
| Revenue | US$31.79m |
| Cost of Revenue | US$8.31m |
| Gross Profit | US$23.48m |
| Other Expenses | US$27.67m |
| Earnings | -US$4.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 73.86% |
| Net Profit Margin | -13.20% |
| Debt/Equity Ratio | 0% |
How did BWAY perform over the long term?
See historical performance and comparison